YNWIM
2021-08-02

Company is still very attractive and underpriced ..Final Phase 3 readout of the Pancreatic cancer trial and BLA filing for the ALL indication both expected within next 3 months .If everything goes well this company likely to run toward 50 bucks and more. $Erytech Pharma S.A.(ERYP)$

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

发表看法
2